Cited by 43Acne and Rosacea Treatments and EffectsDermatology and Skin DiseasesDermatologic Treatments and Research

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study

Zheng, Yue, Yin, Songchao, Xia, Yue, Chen, Jian, Ye, Congxiu, Zeng, Quanrong, Lai, Wei·2019·Cutaneous and Ocular Toxicology

Abstract

BACKGROUND: Topical drugs for mild to moderate acne include adapalene (ADA) and benzoyl peroxide(BPO). Supramolecular salicylic acid (SSA), a modified SA preparation, is considered as a new effective therapeutic scheme. OBJECTIVES: To compare the safety and efficacy of 2% supramolecular SA (2% SSA) with 0.01% adapalene plus 5% benzoyl peroxide (5%BPO +0.1%ADA) for treatment of facial acne. MATERIALS AND METHODS: This was an open-label, split face, randomized and single-centre clinical trial. Subjects with mild to moderate acne were enrolled. Two percent SSA cream were randomly applied on one side of the face while 5%BPO +0.1%ADA gel was applied on the opposite side for 28 days. The numbers of acne lesions, along with side effects of the targeted area were evaluated by the investigators at day 0, day 14, and day 28. Skin water content, TEWL and skin lightening indexes were measured at the same time. RESULTS: A total of 31 of acne patients completed the trial. Dates showed that 2% SSA had similar effects to 5%BPO +0.1%ADA in reducing papules/pustules (47.9% vs. 49.8%), non-inflammatory lesions (43.1% vs. 42.7%) and total lesions (44.1% vs. 45.6%; all p > 0.05) at day 28. The skin barrier (skin hydration value and TEWL value), skin brightness (L* value) and erythema (a* values) indicators showed no statistical differences in the left and right sides of the face (p > 0.05). CONCLUSION: This study demonstrated that 2% SSA has a similar efficacy with 5%BPO +0.1%ADA in mild to moderate acne treatment. This might be a useful pilot study that could be used to support further larger clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1080/15569527.2018.1518329

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Shalita AR., 1989, Clin Ther, 11, 264
  2. Ricci F, 2016, Eur Rev Med Pharmacol Sci, 20, 232
  3. Del RJ, 2013, J Drugs Dermatol, 12, s109

Cited by

Sorted by citations

Metadata

Authors
Zheng, Y., Yin, S., Xia, Y., Chen, J., Ye, C., Zeng, Q., & Lai, W.
Affiliations
Third Affiliated Hospital of Sun Yat-sen University (CN)
Corresponding author
Lai, Wei
Venue
Cutaneous and Ocular Toxicology
Published
2018-12-20
Volume
38
Issue
1
Pages
48-54
ISSN
  • 1556-9527 (ISSN-L)
  • 1556-9535
OpenAlex
W2889831727
Cited by
43
References
19
Citations by year
2026: 2 · 2025: 7 · 2024: 11 · 2023: 5 · 2022: 8 · 2021: 1 · 2020: 5 · 2019: 4
FWCI
2.72
Type
journal article
Language
en
Open access
closed
Locations
  • Cutaneous and Ocular Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Broda Technologies Co., Ltd.,China
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
Keywords
benzoyl peroxide, adapalene, acne, topical acne treatment, combination therapy, skin barrier function, transepidermal water loss, skin hydration, skin lightness, erythema, treatment safety
MeSH terms
Adapalene, Acne Vulgaris, Administration, Cutaneous, Adolescent, Adult, Benzoyl Peroxide, Dermatologic Agents, Drug Combinations, Female, Humans, Male, Treatment Outcome, Salicylic Acid, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review